How long should I take Erdafitinib?

The length of time a drug should be used usually depends on the patient's specific condition, the severity of the disease, and the recommendations of the doctor. Erdafitinib (Erdafitinib) is mainly studied and approved for the treatment of advanced or metastatic urothelial cancer (UC), and the specific treatment plan needs to be determined based on the patient's condition and the doctor's recommendations.

When using erdafitinib, patients usually need to continue treatment until they reach the treatment goals set by their medical team or until they develop intolerable side effects. The length of treatment may vary depending on changes in the patient's condition, efficacy, tolerance, etc.

Doctors typically monitor patients' conditions regularly, including using imaging studies and laboratory tests to assess whether tumors are shrinking or stabilizing. Based on these monitoring results, doctors can adjust the treatment plan, including continuing erdafitinib treatment, adjusting the dose, and trying other treatment options.

When using any medication, patients should follow their doctor's recommendations and take the medication on time according to the prescribed dosage and schedule. At the same time, if the patient encounters any discomfort or side effects during treatment, he should communicate with the doctor in time so that the doctor can make timely adjustments or provide supportive treatment.

Erdafitinib is not currently available in the country, so patients cannot purchase it domestically and need to purchase erdafitinib through foreign channels. The original drug of erdafitinib is mainly the Hong Kong version of the original drug, with a price of more than 20,000, and needs to be purchased through a Hong Kong pharmacy. The generic drugs are relatively cheaper, mainly the Laos version and the Bangladesh Yaopin International version, with a price of about 1,000 to 2,000, and the ingredients of the original drug and the generic drug are basically the same.

xa0

xa0